Most systemic autoimmune diseases occur more frequently in females than in males. This is particularly evident in Sjö gren's syndrome, systemic lupus erythromatosis (SLE) and thyroid autoimmunity, where the ratio of females to males ranges from 20:1 to 8:1. Our understanding of the etiology of SLE implies important roles for genetics, environmental factors and sex hormones, but the relative significance of each remains unknown. Using the New Zealand hybrid mouse model system of SLE, we present here a new fetal liver chimera-based system in which we can segregate effects of immune system genes from that of sex hormones in vivo. We show that female hematopoietic cells express an intrinsic capacity to drive lupus-like disease in both male and female recipient mice, suggesting that this capacity is hormone independent. Particularly, only chimeric mice with a female hematopoietic system showed significantly increased numbers of germinal center B cells, memory B cells and plasma cells followed by a spontaneous loss of tolerance to nuclear components and hence elevated serum antinuclear autoantibodies. A protective effect of testosterone was noted with regard to disease onset, but not disease incidence. Thus, genetic factors encoded within the female hematopoietic system can effectively drive lupus-like disease even in male recipients.
INTRODUCTION
Autoimmune diseases such as systemic lupus erythematosus (SLE) have a strong female bias. 1 A female predominance is also observed in the New Zealand hybrid mouse model of SLE ((NZB Â NZW)F1), where 100% of female mice but o40% of male mice develop end-stage renal disease within 1 year of age. 2, 3 Lupus-like disease in (NZB Â NZW)F1 mice is characterized by elevated antinuclear autoantibodies (ANA), IgG-immune complex deposition and complement fixation in the kidney glomeruli, and glomerulonephritis resembling the human disorder. 4 The disease is generally believed to be mediated by immune system defects as shown in bone marrow (BM) transfer studies. 5 Levels of sex hormones or differences in sex-linked gene expression patterns are proven explanations for the pronounced sex difference observed for (NZB Â NZW)F1 lupus-like disease. In this regard, prepubertal hormonal manipulation studies have shown a protective effect of testosterone and exacerbating effect of estrogens. 3, [6] [7] [8] [9] In addition, exposure to sex hormones during embryogenesis can affect autoimmune development in adult mice. 10 Genetic overexpression of X-linked genes, as seen in mice carrying the Yaa lupus susceptibility locus, has also been strongly associated with disease development. 11, 12 Particularly, a link between copies of Tlr7 and the development of ANA have been demonstrated, [12] [13] [14] [15] although other genes expressed on the X chromosome probably also have a role, as demonstrated in toll-like receptor 7 (TLR7)-deficient male B6.Nba2(Yaa) congenic lupus-prone mice. 16 Also supporting an effect of the X chromosome are data showing a correlation between pristaneinduced lupus-like disease and X-chromosome dosage in castrated Sry-transgenic male mice and the accelerated spontaneous development of lupus in XX versus XY À NZM2328 mice. 17 Type I interferons (interferon-a (IFNa)) have a crucial role in SLE and lupus-like disease development. 18, 19 In (NZB Â NZW)F1 mice, elevation of the levels of IFNa increases autoantibody production and accelerates renal disease onset. 20 IFNa can be produced by many cell subsets, but most noticeably by plasmacytoid dendritic cells in response to a variety of stimuli targeting intracellular TLR 7, 8 and 9 and cytoplasmic DNA sensors such as Aim2, DAI/ZBP1, Lrrfip1 and IFI16 (Ifi204). [21] [22] [23] [24] IFNa is known to affect T cells, as well as B cells, although whether one or both mechanisms are involved in IFNa-driven lupus-like disease is still unknown. 25, 26 In this study, we investigated whether female hematopoietic stem and progenitor cells were capable of driving autoimmunity in the presence of male and/or female sex hormones. Using a mixed sex chimera system, we found that female hematopoietic cells (HCs) could drive the development of lupus-like renal disease, elevated levels of germinal center B cells, memory B cells and plasma cells, and increased ANA in all recipients, regardless of sex hormone levels. In addition, mice receiving female HCs expressed elevated levels of serum IFNa before the generation of ANA and the onset of renal disease. Male recipients of female HCs exhibited a delay in the onset of disease as compared with female recipients, suggesting that the protective effect of testosterone affected early events in disease propagation only. Thus, 1 surprisingly the disease-driving capacity of female HCs appears more potent in driving disease than the known protective effect of testosterone.
RESULTS
Female BM cells transfer renal disease into male and female recipients with a higher incidence and faster kinetic than male BM cells Estrogens are known to promote lupus-like disease development in (NZB Â NZW)F1 mice, while testosterone has been found to protect against the disease. 6, 7 In addition, X-chromosome dosage has been found to affect disease development in other mouse models of SLE. 17, 27 As sex hormones affect the immune system, 28, 29 distinguishing the effect of hormones from the effect of genes has been challenging. We asked if female HCs from (NZB Â NZW)F1 mice could transfer disease into hormonally intact, lethally irradiated, age-matched male recipients. The major male antigen H-Y is not presented by H2d and H2z, allowing such reconstitution to occur without rejection. 30 To avoid potential effects of pubertal sex hormones, we performed the experiments using 4-week-old, prepubertal mice. Female HCs were capable of driving lupus-like renal disease in 100% of recipient mice by 31 weeks after transfer, regardless of the sex of the recipient mouse ( Figure 1a ). In contrast, within the same time frame, male HCs transferred disease into 57% and 25% of female and male recipients, respectively (Figure 1a, Po0.05-0.001). Even when kept until 1 year of age (48 weeks after transfer), only B85% of recipient mice accepting male HCs developed renal disease (Po0.001). Irradiation and reconstitution itself accelerated endstage lupus-like disease development in all recipient mice regardless of sex, although the characteristic difference between control male-into-male and female-into-female remained statistically significant (Po0.001). Disease onset was similar in male and female mice receiving female BM cells, while male-into-male BM chimera mice started developing disease slightly later than maleinto-female BM chimera mice (Figure 1a , not statistically significant).
The differential disease development was not driven by differences within the stem cell and progenitor cell compartment of male and female recipients, as BM samples from 4-week-old unmanipulated male and female (NZB Â NZW)F1 mice showed equivalent levels of hematopoietic stem cells, common myeloid progenitors, common lymphoid progenitors, granulocytemacrophage progenitors and megakaryocyte-erythrocyte progenitors (Figure 1b) . In addition, all mice analyzed had grafted successfully, as noted by the relative expression of Xist and Uty transcripts in peripheral blood mononuclear cell (PBMC) fractions from mice receiving female or male HCs (Figure 1c) . Moreover, recipient mice continued to express sex hormones at levels equivalent to unmanipulated mice, as determined by serum levels of estradiol and testosterone (Figures 1d and e) . Thus, female HCs from prepubertal 4-week-old (NZB Â NZW)F1 mice transferred Figure 1 . Female prepubertal BM cells transfer lupus-like disease in a hormone-independent manner. Four-week-old (NZB Â NZW)F1 male and female mice were lethally irradiated and reconstituted with male or female BM cells from age-matched mice. (a) Mice were followed for the development of renal disease by detection of proteinuria every 2 weeks. Mice with severe proteinuria (4100 mg dl À 1 on two consecutive readings) were considered positive. All mice were killed 48 weeks after transfer, regardless of disease stage. Female-into-female (open square, n ¼ 6); female-intomale (light gray triangle, n ¼ 8); male-into-female (dark gray triangle, n ¼ 7); male-into-male (filled circle, n ¼ 8). (b) BM cells were isolated from 4-week-old unmanipulated (NZB Â NZW)F1 mice (n ¼ 5 for both males and females) and the proportions of hematopoietic stem cells and progenitor cell subsets were determined by flow cytometry. (c) PBMCs were isolated from BM chimera mice 18 weeks after transfer (n ¼ 2 of each). Total RNA was isolated and cDNA generated. The levels of Xist and Uty transcripts were normalized to the levels of b-2-microglobulin and the % was calculated relative to the levels in control female-into-female (100% Xist) or male-into-male (100% Uty) BM chimera mice. (d and e) Serum was isolated from BM chimera mice 18 weeks after transfer and levels of testosterone (d) and estradiol (e) were measured by ELISA. Female recipient: n ¼ 13 (testosterone), n ¼ 6 (estradiol); male recipient: n ¼ 15 (testosterone), n ¼ 5 (estradiol); female control: n ¼ 10 (testosterone), n ¼ 10 (estradiol); male control: n ¼ 6 (testosterone), n ¼ 7 (estradiol). ***Po0.001.
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A David et al accelerated renal disease into both male and female age-matched (NZB Â NZW)F1 mice independently of the recipient's sex hormone environment.
The capacity of female HCs to transfer renal disease is present in utero Sex hormones are produced at high levels starting at puberty. However, even in utero and during the postnatal period sex hormones are produced, and hence HCs from 4-week-old female (NZB Â NZW)F1 mice could have acquired their autoimmune capacities as a result of such exposure. To test for this possibility, we generated fetal liver (FL) chimera mice. FL cells were isolated from male or female (NZB Â NZW)F1 embryos at days E13.5-E14.5 and transferred into lethally irradiated 4-week-old prepubertal male or female (NZB Â NZW)F1 mice. Mice were followed for the development of proteinuria until 32 weeks after transfer. Again, we did not find this to be a result of differences among the transferred HCs, as analyses of FL cells from male and female (NZB Â NZW)F1 embryos showed no differences in the distribution of cell subsets ( Figure 2c ). Similar to the BM chimeric mice, serum levels of sex hormones in FL chimeric recipient mice were comparable to that of unmanipulated male and female (NZB Â NZW)F1 mice (data not shown).
Reconstitution with female FL cells specifically affects levels of postactivation B-cell subsets Lupus is a B-cell and autoantibody-mediated disorder. We tested if B-cell numbers and subset distribution were different between the four groups of FL chimera mice. Gating strategies are depicted in Figures 3a-d Figure 2 . Female FL cells transfer lupus-like disease into both male and female recipients with 100% incidence. Four-week-old (NZB Â NZW)F1 male and female mice were lethally irradiated and reconstituted with male or female FL cells from E14.5 male or female (NZB Â NZW)F1 embryos. (a) Two cohorts of FL chimera mice were followed for the development of renal disease by detection of proteinuria every 2 weeks. Mice with severe proteinuria (4100 mg dl À 1 on two consecutive readings) were considered positive. All mice were killed 35 (cohort 1) or 32 (cohort 2) weeks after transfer, regardless of disease stage. Female-into-female (open square, n ¼ 10); female-into-male (light gray triangle, n ¼ 12); maleinto-female (dark gray triangle, n ¼ 7); male-into-male (filled circle, n ¼ 4). (Figures 3h-j , Po0.05-0.01). Consistent with a female-driven effect driving differentiation of mature B cells in the periphery, we found no differences among the relative levels of pro-B, pre-B and immature B-cell subsets in the BM of FL chimera mice (data not shown).
Autoantibody production is driven by female HCs and not affected by the presence of male sex hormone Female (NZB Â NZW)F1 mice develop hypergammaglobulinemia at early ages followed by a specific loss of tolerance to nuclear autoantigens. 31, 32 We analyzed whether total immunoglobulin and ANA levels were associated with the sex of the FL donor in our chimera system. Increased levels of total IgG, IgG 1 and IgG 2A in the serum of FL chimera mice did not correlate with the groups of mice developing renal disease (Figures 4a-c) . In fact, male-into-male FL chimera mice, which did not develop lupus-like disease, had the highest levels of circulating total immunoglobulins. In contrast, the levels of anti-chromatin IgG, anti-histone IgG and anti-dsDNA IgG were all significantly elevated in chimera mice that had received female FL cells as compared with those mice receiving male FL cells (Figures 4d-f , Po0.05-0.001), suggesting that mice that had received female HCs displayed a specific loss of tolerance to nuclear antigens. Levels of serum IFNa, but not BAFF, are elevated in chimera mice receiving female FL cells The data above suggest that loss of tolerance to nuclear antigens and renal disease is accelerated by female HCs. Possibly explanations for this observation include an increased capacity of female-derived B cells to differentiate into autoantibodyproducing cells or increased levels of B-cell-differentiating signals secreted by female-derived non-B-cell HCs. To test the latter idea, we examined FL chimera mice for levels of serum B-cell-activating Each symbol represents one mouse. *Po0.05; **Po0.01. Brackets in black indicate statistical differences between groups receiving male or female FL cells, while brackets in gray represent statistical differences between individual groups of chimeras. Mice analyzed included female-into-female (n ¼ 9), female-into-male (n ¼ 11), male-into-female (n ¼ 7) and male-into-male (n ¼ 3) FL chimeric mice.
Intrinsic capacity of female hematopoietic cells to drive SLE A David et al factor (BAFF) at 16 weeks after irradiation and reconstitution, before the onset of renal disease. BAFF is known to be involved in B-cell survival and differentiation and has previously been found to be associated with lupus in several mouse models. 33-37 FL chimera mice that had received female HCs did not express elevated levels of BAFF (Figure 5a ). In fact, male FL chimera mice were found to express higher levels of BAFF than female FL chimera mice, regardless of whether these had received male or female FL cells (Po0.05).
IFN a is also known to influence B-cell differentiation 38 and is capable of driving disease development in (NZB Â NZW)F1 mice and related strains. 20, [39] [40] [41] We tested serum levels of IFNa in FL chimera mice 12 weeks after irradiation and reconstitution, before the onset of renal disease. Mice reconstituted with female FL cells displayed higher levels of serum IFNa than mice reconstituted with male FL cells (Figure 5b , female versus male donor: Po0.05). Furthermore, levels of serum IFNa at 12 weeks after transfer correlated statistically with levels of serum anti-chromatin IgG (Po0.001), anti-histones IgG (Po0.05) and anti-dsDNA IgG (Po0.05) measured 20 weeks after transfer (Figures 5c-e) . Serum IFNa levels measured 12 weeks after reconstitution also trended toward a negative correlation with the onset of renal disease in all FL chimeras (Figure 5f , P ¼ 0.1).
DISCUSSION
Although tremendous amounts of research have gone into determining the etiology of SLE, the underlying mechanism(s) driving disease initiation and/or progression are still poorly defined. We and others have previously shown that manipulation of sex hormone production from puberty significantly alters the development of renal disease.
3,6-9 Specifically, castration of male lupus-prone (NZB Â NZW)F1 mice was found to remove the protective effect of testosterone, resulting in disease development equivalent to that of female unmanipulated mice. 3, 6 Conversely, ovariectomy of female (NZB Â NZW)F1 mice before puberty fails to alter disease kinetics, 6, 8 suggesting that after the immune system is established in female mice around 2-3 weeks of age, estrogens are not crucial for disease progression. Here we have shown that female HCs are capable of driving lupus-like disease in hormonally intact, lethally irradiated male (NZB Â NZW)F1 FL recipient mice. Thus, even in the presence of testosterone, female HCs from lupus-prone (NZB Â NZW)F1 mice cannot be held back and proceed to generate autoreactive B cells, followed by IgG-immune complex deposition, glomerulonephritis and renal failure.
Pre-B-cell lines from FLs of lupus-prone (NZB Â NZW)F1 mice have previously been shown to possess intrinsic autoimmune -13 ), female-into-male (n ¼ 11-13), male-into-female (n ¼ 7-8) and male-into-male (n ¼ 4-8) FL chimeric mice along with 6-9 female and 6 male unmanipulated age-matched controls.
Intrinsic capacity of female hematopoietic cells to drive SLE A David et al competencies when compared with pre-B-cell lines established from non-lupus-prone strains; 42 however, whether these cell lines were of a male or female origin was not reported and remains unknown. As the immune system of FL chimera mice originates from transferred stem cells and progenitor cells, rather than more mature lymphocytes, our data suggest that the defect is genetically encoded. A major player in B-cell development and differentiation is Bruton's tyrosine kinase (Btk) encoded by the X chromosome. 43 Although not much is known about Btk levels and activity in lupus, a recent study reported amelioration of end-stage lupus-like disease in older female (NZB Â NZW)F1 mice treated with a Btk inhibitor. 44 The study did not investigate if males were equally susceptible, and thus any sex-driven abnormality remains to be identified. Another candidate gene is Cd40l, also encoded by the X chromosome. CD40L is essential for T-celldependent B-cell activation and has been assigned an essential role in (NZB Â NZW)F1 lupus-like disease development; 45, 46 however, whether CD40L-mediated B-cell activation is differentially active in male and female recipients remains unknown.
IFNa is recognized as a key cytokine in SLE and mouse lupuslike disease. 19, [39] [40] [41] 47, 48 IFNa is predominantly induced in response to viral or intracellular bacterial infections, but although tempting, a cause-and-effect relationship between infections and SLE remains elusive. We observed elevated levels of serum IFNa in chimera mice that had received female HCs, suggesting that dysregulated IFNa production, either directly or via exorbitant endogenous stimuli, is also intrinsically driven by female HCs. Several genes known to be involved in IFNa production and/or responsiveness have been associated with SLE in genome-wide association studies, including Irf5, Irf7, Irf8, Irak1, Tyk2, Stat4 and Fcgr2a among others (reviewed in Bronson et al. 49 ). Of these, Irak1 is particularly interesting. First, the Irak1 gene is encoded on the X chromosome, making it an attractive candidate when studying sex-dependent disease patterns. Secondly, IRAK1 protein is essential for most TLR-mediated intracellular signaling, resulting in IFNa production. And finally, IRAK1 has been shown to be required for SLE serum (that is, IgG-immune complex)-induced plasmacytoid dendritic cell activation and IFNa production.
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Tlr7 is another X-linked gene that has been strongly associated with mouse lupus-like disease, 16, 27 although not directly identified in GWAS studies. Recently, however, TLR7 expression levels were found to correlate with elevated levels of anti-RNA antibodies in SLE patients. 51 TLR7 is expressed by both plasmacytoid dendritic cells and B cells, resulting in IFNa production and B-cell differentiation, 52, 53 and TLR7-deficient lupus-prone mice fail to develop significant levels of ANAs. 27 Whether female plasmacytoid dendritic cells and/or B cells from (NZB Â NZW)F1 mice respond better to TLR7 crosslinking than male cells remains to be determined; however, it is tempting to speculate such a relationship since (1) autoantibody-producing CD11c þ B cells Figure 5 . Elevated serum IFNa levels are driven by the female hematopoietic system and correlates with early disease onset. Serum was obtained from FL chimera mice 12 or 16 weeks after irradiation and reconstitution. Levels of BAFF were measured 16 weeks after transfer (a), while levels of IFNa were measured 12 weeks after transfer (b). Levels of IFNa correlated positively with autoantibody levels measured 20 weeks after irradiation/reconstitution (c-e) and negatively with the onset of disease (f ). Disease onset was defined as the time point where any given mouse presented with severe proteinuria (X100 mg dl À 1 ) for the first of two consecutive readings (also see Figure 2 ). Each symbol represents one FL chimera mouse. *Po0.05. Groups of mice analyzed included female-into-female (n ¼ 7-14), female-into-male (n ¼ 8-12), male-into-female (n ¼ 6-8) and male-into-male (n ¼ 3-8) FL chimeric mice.
Intrinsic capacity of female hematopoietic cells to drive SLE
A David et al depend on TLR7 signaling and are found predominantly in young autoimmune females, 15 and (2) TLR7 agonist stimulation of human PBMCs resulted in significantly more IFNa production from female than male cells. 54, 55 As estrogen receptor a expression is required for disease development in female (NZB Â NZW)F1 mice, it is interesting to note that IFNa induces transcription of the Esr1 gene and subsequent expression of the estrogen receptor a. 56, 57 Oppositely, estrogen treatment has been suggested to drive dendritic cell activation and enhance IFNa production upon at least TLR9 ligation. 58, 59 Whether male and female HCs respond equally to estrogens has been evaluated both in vivo and in vitro in (NZB Â NZW)F1 and non-autoimmune mice, showing no significant differences. 58, 60, 61 On the basis of these observations, we do not believe that the disease-promoting effect of female HCs is because of increased responsiveness of female cells to low levels of estrogens present in male recipients, although further experiments are needed to firmly rule out this possibility.
So what about testosterone and its well-established protective effect? We have recently described the presence of a population of testosterone-induced immunosuppressive myeloid cells (Gr1 high CD11b þ ) in male (NZB Â NZW)F1 mice. 62 These cells have the capacity to directly suppress B-cell differentiation in vitro, while depletion in vivo promotes autoantibody production in male mice. In our chimera system, male recipients experienced a later onset of disease, although autoantibody production seemed to be only marginally lower in male versus female recipients. Comparing intact and castrated male recipient mice after reconstitution with female FL-derived HCs confirmed that the percentage of Gr1 high CD11b þ cells were in fact reduced in castrated male FL recipients (Po0.05); however, autoantibody levels were unchanged (unpublished results). On the basis of these observations, we propose that testosterone may act by promoting the development of immunosuppressive Gr1 high CD11b þ cells capable of delaying, but not inhibiting, disease development. The presence of these cells is subsequently enough to control intrinsic disease-promoting signals in male HCs but not in female HCs, the latter promoting elevated IFNa production, B-cell differentiation, ANA production and fatal renal disease. Taken together, we have found that (NZB Â NZW)F1 female HCs have an intrinsic ability to drive autoimmune lupuslike disease, regardless of the hormonal environment of the host. This strongly implicates genetic rather than hormonal factors as the underlying mechanism driving the increased incidence of autoimmunity in female recipients as compared with male recipients.
MATERIALS AND METHODS

Mice and cells
Three-week-old male and female (NZB Â NZW)F1 mice were obtained from The Jackson Laboratory and kept in a specific pathogen-free environment at National Jewish Health (Denver, CO, USA). All mouse experiments were approved by the local IACUC committee. BM chimera mice were generated by lethal irradiation (1000 rad) using a Cs 137 irradiator of 4-week-old male or female prepubertal (NZB Â NZW)F1 mice. Mice were given acidified water (pH 2.7) to drink throughout the experiment. BM cells were obtained from 4-week-old male or female (NZB Â NZW)F1 mice and 5 Â 10 6 cells were injected intravenously 2-4 h after irradiation. FL single cells were obtained from E13.5 to E14.5 embryos and frozen in 90% fetal bovine serum and 10% dimethylsulfoxide at À 80 1C. The sex of each embryo was determined visually and by real-time reverse transcriptase-polymerase chain reaction analyses of Uty and Xist expression levels (see below). Each FL provided enough cells to reconstitute three recipients via tail vein injection.
Real-time reverse transcriptase-polymerase chain reaction PBMCs were obtained from chimera mice 6 weeks after reconstitution. RNA was isolated using RNeasy Plus Micro Kit (Qiagen, Valencia, CA, USA) and cDNA prepared using the qScript cDNA SuperMix (Quanta BioSciences, Gaithersburg, MD, USA). Polymerase chain reaction was run on a real-time PCR machine (ABI7300; Applied Biosystems, Carlsbad, CA, USA) using the following primers: Xist-F,
0 -TGGTGCATCCAACCTAACTGTT-3 0 . Unmanipulated male and female samples were used separately or in different ratios (1:1, 1:3, 1:9, 1:27) to generate a standard curve. The levels of transcripts in chimera mice were calculated as % of total.
Detection of sex hormones
Estradiol and testosterone were measured by enzyme-linked immunosorbent assay (ELISA) using the manufacturer's protocols (US Biological, Salem, MA, USA). Testosterone levels were measured on 10 times diluted serum. Estradiol levels were measured after extraction. Briefly, 50 ml of serum was vortexed with 500 ml ethyl ether for 30 s. Phases were allowed to separate and the organic phase was transferred to a fresh glass tube. The solvent was allowed to evaporate before the residue was dissolved in 250 ml of extraction buffer.
Antibody ELISA Serum was obtained from chimera mice every 4 weeks starting 8 weeks after irradiation and reconstitution. For detection of total IgG and IgM, serum was diluted 1:50 000-1:200 000 in serum diluent (sterile filtered 0.5% bovine g-globulin, 5% gelatin, 0.05 mM Tween in 1 Â phosphate-buffered saline). For detection of ANAs, serum was diluted 1:300. Levels of anti-chromatin, anti-histone and anti-dsDNA IgG autoantibodies were measured as described previously. 62 All reactions were developed using 10 mg ml À 1 2,2 0 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) in McllWain's buffer (0.09 M Na 2 HPO 4 , 0.06 M citric acid, pH 4.6). Anti-dsDNA IgG levels were determined using the manufacturer's protocol (Alpha Diagnostic International Inc., San Antonio, TX, USA). 
Flow cytometry
Flow cytometry was performed using a Cyan Flow cytometer ADP (Beckman Coulter, Indianapolis, IN, USA) and all analyses were carried out using FlowJo version 9.5.2 (TreeStar Inc., Ashland, OR, USA). Antibodies with the following specificities were used for all analyses: CD11b, CD11c, CD19, CD21, CD23, CD38, CD40, B220 (CD45R), CD138, F4/80, Gr1 (Ly6C/ 6G), IgM and IgD (all from eBiosciences, San Diego, CA, USA). Peanut agglutinin (PNA) was obtained from Vector Laboratories Inc. (Burlingame, CA, USA).
Immunofluorescence staining
IgG deposition and complement factor 3 fixation was measured by immunofluorescence staining. Briefly, half kidneys were quick-frozen in OCT and 5 mm sections were prepared. Sections were stained using Texas Red-conjugated anti-mouse IgG (Invitrogen, Grand Island, NY, USA) and fluorescein isothiocyanate-conjugated anti-mouse complement factor 3-specific antibodies (ICL Inc., Portland, OR, USA). Images were collected using an HC Plan Apo Â 20/0.7NA objective lens on a Leica DMR upright microscope (Leica Microsystems, Buffalo Grove, IL, USA) equipped with a Retiga EXi Cooled CCD Camera (QImaging, Surrey, BC, Canada).
Statistical analyses
All statistical analyses were carried out using GraphPad Prism v. 5.04 (GraphPad Inc., La Jolla, CA, USA). Analyses of cumulative incidence were carried out using a log-rank test (Mantel-Cox test). Comparisons of average time of onset, cellular proportions and serum cytokine levels between two groups were carried out using a two-tailed non-parametric Mann-Whitney test. P-values o0.05 were considered statistically significant.
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